Selected research
Market Structure
Global Sex Hormones Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Sex Hormones market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Sex Hormones is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Sex Hormones is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Sex Hormones is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Sex Hormones is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Sex Hormones include Zizhu Pharma, Sanofi, Novartis, Merck, Pfizer, GSK, Bayer, AstraZeneca and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Sex Hormones market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Sex Hormones and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Sex Hormones sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sex Hormones market size, projected growth trends, production technologies, key applications, and end-use industries.
Sex Hormones Segment by Company
Zizhu Pharma
Sanofi
Novartis
Merck
Pfizer
GSK
Bayer
AstraZeneca
Cipla
Sex Hormones Segment by Type
Drospirenone
Progesterone
Testosterone
Others
Sex Hormones Segment by Application
Injection
Inhalation
Oral
Topical
Sex Hormones Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sex Hormones market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sex Hormones and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sex Hormones.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Sex Hormones market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sex Hormones manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sex Hormones in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Sex Hormones in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Drospirenone
- Progesterone
- Testosterone
- Others
Applications
- Injection
- Inhalation
- Oral
- Topical
Companies covered
- Zizhu Pharma
- Sanofi
- Novartis
- Merck
- Pfizer
- GSK
- Bayer
- AstraZeneca
- Cipla
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Sex Hormones Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Sex Hormones Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Sex Hormones Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Sex Hormones Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Sex Hormones Market Dynamics
- 2.1 Sex Hormones Industry Trends
- 2.2 Sex Hormones Industry Drivers
- 2.3 Sex Hormones Industry Opportunities and Challenges
- 2.4 Sex Hormones Industry Restraints
3 Sex Hormones Market by Manufacturers
- 3.1 Global Sex Hormones Revenue by Manufacturers (2021-2026)
- 3.2 Global Sex Hormones Sales by Manufacturers (2021-2026)
- 3.3 Global Sex Hormones Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Sex Hormones Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sex Hormones Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Sex Hormones Manufacturers, Product Type & Application
- 3.7 Global Sex Hormones Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Sex Hormones Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Sex Hormones Players Market Share by Revenue in 2025
- 3.8.3 2025 Sex Hormones Tier 1, Tier 2, and Tier 3
4 Sex Hormones Market by Type
- 4.1 Sex Hormones Type Introduction
- 4.1.1 Drospirenone
- 4.1.2 Progesterone
- 4.1.3 Testosterone
- 4.1.4 Others
- 4.2 Global Sex Hormones Sales by Type
- 4.2.1 Global Sex Hormones Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Sex Hormones Sales by Type (2021-2032)
- 4.2.3 Global Sex Hormones Sales Market Share by Type (2021-2032)
- 4.3 Global Sex Hormones Revenue by Type
- 4.3.1 Global Sex Hormones Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Sex Hormones Revenue by Type (2021-2032)
- 4.3.3 Global Sex Hormones Revenue Market Share by Type (2021-2032)
5 Sex Hormones Market by Application
- 5.1 Sex Hormones Application Introduction
- 5.1.1 Injection
- 5.1.2 Inhalation
- 5.1.3 Oral
- 5.1.4 Topical
- 5.2 Global Sex Hormones Sales by Application
- 5.2.1 Global Sex Hormones Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Sex Hormones Sales by Application (2021-2032)
- 5.2.3 Global Sex Hormones Sales Market Share by Application (2021-2032)
- 5.3 Global Sex Hormones Revenue by Application
- 5.3.1 Global Sex Hormones Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Sex Hormones Revenue by Application (2021-2032)
- 5.3.3 Global Sex Hormones Revenue Market Share by Application (2021-2032)
6 Global Sex Hormones Sales by Region
- 6.1 Global Sex Hormones Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Sex Hormones Sales by Region (2021-2032)
- 6.2.1 Global Sex Hormones Sales by Region (2021-2026)
- 6.2.2 Global Sex Hormones Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Sex Hormones Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Sex Hormones Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Sex Hormones Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Sex Hormones Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Sex Hormones Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Sex Hormones Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Sex Hormones Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Sex Hormones Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Sex Hormones Revenue by Region
- 7.1 Global Sex Hormones Revenue by Region
- 7.1.1 Global Sex Hormones Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Sex Hormones Revenue by Region (2021-2026)
- 7.1.3 Global Sex Hormones Revenue by Region (2027-2032)
- 7.1.4 Global Sex Hormones Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Sex Hormones Revenue (2021-2032)
- 7.2.2 North America Sex Hormones Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Sex Hormones Revenue (2021-2032)
- 7.3.2 Europe Sex Hormones Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Sex Hormones Revenue (2021-2032)
- 7.4.2 Asia-Pacific Sex Hormones Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Sex Hormones Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Sex Hormones Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Zizhu Pharma
- 8.1.1 Zizhu Pharma Company Information
- 8.1.2 Zizhu Pharma Business Overview
- 8.1.3 Zizhu Pharma Sex Hormones Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Zizhu Pharma Sex Hormones Product Portfolio
- 8.1.5 Zizhu Pharma Recent Developments
- 8.2 Sanofi
- 8.2.1 Sanofi Company Information
- 8.2.2 Sanofi Business Overview
- 8.2.3 Sanofi Sex Hormones Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sanofi Sex Hormones Product Portfolio
- 8.2.5 Sanofi Recent Developments
- 8.3 Novartis
- 8.3.1 Novartis Company Information
- 8.3.2 Novartis Business Overview
- 8.3.3 Novartis Sex Hormones Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Novartis Sex Hormones Product Portfolio
- 8.3.5 Novartis Recent Developments
- 8.4 Merck
- 8.4.1 Merck Company Information
- 8.4.2 Merck Business Overview
- 8.4.3 Merck Sex Hormones Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Merck Sex Hormones Product Portfolio
- 8.4.5 Merck Recent Developments
- 8.5 Pfizer
- 8.5.1 Pfizer Company Information
- 8.5.2 Pfizer Business Overview
- 8.5.3 Pfizer Sex Hormones Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Pfizer Sex Hormones Product Portfolio
- 8.5.5 Pfizer Recent Developments
- 8.6 GSK
- 8.6.1 GSK Company Information
- 8.6.2 GSK Business Overview
- 8.6.3 GSK Sex Hormones Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 GSK Sex Hormones Product Portfolio
- 8.6.5 GSK Recent Developments
- 8.7 Bayer
- 8.7.1 Bayer Company Information
- 8.7.2 Bayer Business Overview
- 8.7.3 Bayer Sex Hormones Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Bayer Sex Hormones Product Portfolio
- 8.7.5 Bayer Recent Developments
- 8.8 AstraZeneca
- 8.8.1 AstraZeneca Company Information
- 8.8.2 AstraZeneca Business Overview
- 8.8.3 AstraZeneca Sex Hormones Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 AstraZeneca Sex Hormones Product Portfolio
- 8.8.5 AstraZeneca Recent Developments
- 8.9 Cipla
- 8.9.1 Cipla Company Information
- 8.9.2 Cipla Business Overview
- 8.9.3 Cipla Sex Hormones Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Cipla Sex Hormones Product Portfolio
- 8.9.5 Cipla Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Sex Hormones Value Chain Analysis
- 9.1.1 Sex Hormones Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Sex Hormones Production Mode & Process
- 9.2 Sex Hormones Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Sex Hormones Distributors
- 9.2.3 Sex Hormones Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst